A detailed history of Xtx Topco LTD transactions in Myriad Genetics Inc stock. As of the latest transaction made, Xtx Topco LTD holds 64,080 shares of MYGN stock, worth $687,578. This represents 0.08% of its overall portfolio holdings.

Number of Shares
64,080
Previous 11,157 474.35%
Holding current value
$687,578
Previous $305,000 187.87%
% of portfolio
0.08%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$13.17 - $27.03 $696,995 - $1.43 Million
52,923 Added 474.35%
64,080 $878,000
Q3 2024

Nov 14, 2024

SELL
$23.97 - $28.6 $32,838 - $39,182
-1,370 Reduced 10.94%
11,157 $305,000
Q2 2024

Aug 12, 2024

BUY
$17.98 - $25.47 $225,235 - $319,062
12,527 New
12,527 $306,000
Q2 2023

Aug 14, 2023

BUY
$17.56 - $23.76 $172,527 - $233,442
9,825 New
9,825 $227,000
Q2 2021

Aug 12, 2021

SELL
$25.39 - $32.61 $253,239 - $325,252
-9,974 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$19.92 - $31.6 $198,682 - $315,178
9,974 New
9,974 $304,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $865M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.